CAVERJECT Drug Patent Profile
✉ Email this page to a colleague
When do Caverject patents expire, and when can generic versions of Caverject launch?
Caverject is a drug marketed by Pfizer and is included in three NDAs.
The generic ingredient in CAVERJECT is alprostadil. There are seven drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the alprostadil profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Caverject
A generic version of CAVERJECT was approved as alprostadil by HIKMA on January 20th, 1998.
Summary for CAVERJECT
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 3 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 105 |
Clinical Trials: | 1 |
Patent Applications: | 4,231 |
Drug Prices: | Drug price information for CAVERJECT |
What excipients (inactive ingredients) are in CAVERJECT? | CAVERJECT excipients list |
DailyMed Link: | CAVERJECT at DailyMed |
Recent Clinical Trials for CAVERJECT
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
City of Hope Medical Center | Phase 3 |
Pharmacology for CAVERJECT
Drug Class | Prostaglandin Analog Prostaglandin E1 Agonist |
Mechanism of Action | Prostaglandin Receptor Agonists |
Physiological Effect | Genitourinary Arterial Vasodilation Venous Vasodilation |
Anatomical Therapeutic Chemical (ATC) Classes for CAVERJECT
US Patents and Regulatory Information for CAVERJECT
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pfizer | CAVERJECT | alprostadil | INJECTABLE;INJECTION | 020379-003 | Jun 27, 1996 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Pfizer | CAVERJECT | alprostadil | INJECTABLE;INJECTION | 020379-004 | May 19, 1997 | AP | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Pfizer | CAVERJECT | alprostadil | INJECTABLE;INJECTION | 020755-002 | Oct 1, 1997 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Pfizer | CAVERJECT IMPULSE | alprostadil | INJECTABLE;INJECTION | 021212-001 | Jun 11, 2002 | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Pfizer | CAVERJECT | alprostadil | INJECTABLE;INJECTION | 020755-001 | Oct 31, 1997 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for CAVERJECT
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Pfizer | CAVERJECT | alprostadil | INJECTABLE;INJECTION | 020379-001 | Jul 6, 1995 | ⤷ Try a Trial | ⤷ Try a Trial |
Pfizer | CAVERJECT | alprostadil | INJECTABLE;INJECTION | 020379-002 | Jul 6, 1995 | ⤷ Try a Trial | ⤷ Try a Trial |
Pfizer | CAVERJECT | alprostadil | INJECTABLE;INJECTION | 020379-003 | Jun 27, 1996 | ⤷ Try a Trial | ⤷ Try a Trial |
Pfizer | CAVERJECT | alprostadil | INJECTABLE;INJECTION | 020379-004 | May 19, 1997 | ⤷ Try a Trial | ⤷ Try a Trial |
Pfizer | CAVERJECT | alprostadil | INJECTABLE;INJECTION | 020379-002 | Jul 6, 1995 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for CAVERJECT
See the table below for patents covering CAVERJECT around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
New Zealand | 273752 | STABILISED PROSTAGLANDIN E1 LYOPHILISATE USING TERTIARY BUTANOL AND LACTOSE CARRIERS | ⤷ Try a Trial |
Greece | 3032817 | ⤷ Try a Trial | |
Denmark | 0725642 | ⤷ Try a Trial | |
Finland | 961797 | ⤷ Try a Trial | |
European Patent Office | 0725642 | PROSTAGLANDINE E 1 STABILISEE (STABILIZED PROSTAGLANDIN E 1) | ⤷ Try a Trial |
>Country | >Patent Number | >Title | >Estimated Expiration |